Immunetrics

Immunetics, Inc. is a Pittsburgh-based biosimulation company with two decades of experience providing predictive modeling solutions to support clinical trial design for large pharmaceutical companies. Immunetics' modeling and simulation capabilities offer decision-support information to our clients across all stages of drug development, including preclinical target identification, trial design, combination drug synergy, target patient populations, new indications, and FDA requirements. Immunetics' technology includes an extensive and continually expanding library of standardized disease progression models and Thales (a comprehensive QSP model development platform).